These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 5936954

  • 1. Conversion of 6-chloropurine to its ribonucleotide by ascites tumor cells.
    Hampton A, Paterson AR.
    Biochim Biophys Acta; 1966 Jan 18; 114(1):185-7. PubMed ID: 5936954
    [No Abstract] [Full Text] [Related]

  • 2. Comparative studies on the in vivo action of 6-chloropurine, 6-chloropurine ribonucleoside, and 6-chloro-9-ethylpurine on sarcoma 180 ascites cells.
    SARTORELLI AC, BOOTH BA.
    J Pharmacol Exp Ther; 1961 Oct 18; 134():123-8. PubMed ID: 14497281
    [No Abstract] [Full Text] [Related]

  • 3. The effect of D-glucosamine on the adenine and uridine nucleotides of sarcoma 180 ascites tumor cells.
    Bekesi JG, Winzler RJ.
    J Biol Chem; 1969 Oct 25; 244(20):5663-8. PubMed ID: 5360467
    [No Abstract] [Full Text] [Related]

  • 4. Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
    SARTORELLI AC, BOOTH BA.
    Biochem Pharmacol; 1960 Nov 25; 5():245-50. PubMed ID: 13746610
    [No Abstract] [Full Text] [Related]

  • 5. Limited phosphorylation of some 6-methylaminopurine nucleosides.
    Shigeura HT, Sampson SD, Meloni ML.
    Arch Biochem Biophys; 1966 Sep 09; 115(3):462-7. PubMed ID: 6008130
    [No Abstract] [Full Text] [Related]

  • 6. [The use of labelled cells and chemical compounds for the analysis of the mechanism of action of cytotoxic substances].
    Lettré H.
    Nucl Med (Stuttg); 1965 Sep 09; 2():3-16. PubMed ID: 5888973
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of the synthesis of thymine nucleotides by azaserine.
    Sartorelli AC, Booth BA.
    Mol Pharmacol; 1967 Jan 09; 3(1):71-80. PubMed ID: 6067695
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of the biosynthesis of purines de novo by 6-chloropurine and azaserine in sensitive and naturally resistant ascites cells.
    SARTORELLI AC, AKERS JR, BOOTH BA.
    Biochem Pharmacol; 1960 Nov 09; 5():238-44. PubMed ID: 13746609
    [No Abstract] [Full Text] [Related]

  • 9. N6-(delta2-isopentenyl)adenosine 5'-monophosphate: formation and effect on purine metabolism in cellular and enzymatic systems.
    Divekar AY, Slocum HK, Hakala MT.
    Mol Pharmacol; 1974 May 09; 10(3):529-43. PubMed ID: 4368972
    [No Abstract] [Full Text] [Related]

  • 10. Feedback inhibition of purine biosynthesis in adenocarcinoma 755 and sarcoma 180 cells in culture.
    Dixon GJ, Dulmadge EA, Brockman RW, Shaddix SC.
    J Natl Cancer Inst; 1970 Oct 09; 45(4):681-5. PubMed ID: 5535124
    [No Abstract] [Full Text] [Related]

  • 11. The metabolism of 6-chloropurine-8-C14 in the rat.
    DUGGAN DE, TITUS E.
    J Pharmacol Exp Ther; 1960 Dec 09; 130():375-82. PubMed ID: 13724820
    [No Abstract] [Full Text] [Related]

  • 12. Pattern of [32P]orthophosphate incorporation in vitro into ribonucleic acid nucleotides of Ehrlich ascites tumor cells.
    Hadjiolov AA, Venkov PV, Dolapchiev LB.
    Biochim Biophys Acta; 1965 Oct 11; 108(2):220-32. PubMed ID: 5893630
    [No Abstract] [Full Text] [Related]

  • 13. Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine.
    Bennett LL, Allan PW.
    Cancer Res; 1971 Feb 11; 31(2):152-8. PubMed ID: 5545266
    [No Abstract] [Full Text] [Related]

  • 14. Changes in sarcoma 180 cells associated with drug-induced resistance to adenosine analogs.
    Divekar AY, Fleysher MH, Slocum HK, Kenny LN, Hakala MT.
    Cancer Res; 1972 Nov 11; 32(11):2530-7. PubMed ID: 4263645
    [No Abstract] [Full Text] [Related]

  • 15. Formation of 6-thioxanthosine 5'-phosphate from 6-mercaptopurine and from 6-thioxanthine in Ehrlich ascites-tumour cells.
    Atkinson MR, Eckermann G, Stephenson J.
    Biochim Biophys Acta; 1965 Oct 11; 108(2):320-2. PubMed ID: 5893632
    [No Abstract] [Full Text] [Related]

  • 16. Synergistic effect of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside on the levels of adenine nucleotides of Sarcoma 180 cells.
    Scholar EM, Brown PR, Parks RE.
    Cancer Res; 1972 Feb 11; 32(2):259-69. PubMed ID: 5058187
    [No Abstract] [Full Text] [Related]

  • 17. THE INTERCONVERSION OF PURINES BY TUMORS AND THE ACTION OF ANTI-PURINES.
    BALIS ME, SALSER JS.
    Acta Unio Int Contra Cancrum; 1964 Feb 11; 20():115-7. PubMed ID: 14151863
    [No Abstract] [Full Text] [Related]

  • 18. Distribution of tritiated methyl ester of streptonigrin in mice bearing sarcoma 180.
    Mizuno NS.
    Biochem Pharmacol; 1966 Mar 11; 15(3):394-5. PubMed ID: 5911549
    [No Abstract] [Full Text] [Related]

  • 19. Secretion of purines by the small intestine: general characteristics.
    Berlin RD, Hawkins RA.
    Am J Physiol; 1968 Oct 11; 215(4):932-41. PubMed ID: 5676397
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical effects of formycin, an adenosine analog.
    Henderson JF, Paterson AR, Caldwell IC, Hori M.
    Cancer Res; 1967 Apr 11; 27(4):715-9. PubMed ID: 4290625
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.